Association of Diabetes Care & Education Specialists

News & Publications

Perspectives on Diabetes Care

Perspectives on Diabetes Care is the official blog of the Association of Diabetes Care & Education Specialists. It features practical tips, the latest research and viewpoints from leading diabetes care and education specialists on issues facing the diabetes care team and those they serve.
  • CBDCE Announces Extension of Temporary Changes for Initial CDCES Certification

    By ADCES Perspectives on Diabetes Care | Aug 01, 2022

    Sheryl Traficano outlines the efforts made by the CBDCE Board of Directors to address the impact of the COVID-19 pandemic on the ability of health care professionals pursuing the Certified Diabetes Care and Education Specialist® (CDCES®) credential.

  • ADCES22 Research: Let’s Connect and Inspire!

    By ADCES Perspectives on Diabetes Care | Jul 25, 2022

    There is no better place than the ADCES Annual Conference in Baltimore to learn about emerging science and research in diabetes care and education! Mark your calendar to attend one of the ADCES22 research-focused sessions at ADCES22.

  • Diabetes in Practice at ADCES22 – Get Ready to Maximize Your Impact

    By ADCES Perspectives on Diabetes Care | Jul 18, 2022

    Christina Dauer MPH, RDN, LDN, CDCES gives a preview of the ADCES22 sessions in the Diabetes in Practice track — created to help both new and seasoned DCESs develop skills in patient care, population health and advocacy.

  • The Importance of Cardiovascular Expertise in Diabetes Prevention, Care and Education 

    By ADCES Perspectives on Diabetes Care | Jul 13, 2022

    Cardiovascular-specific knowledge helps the DCES treat the whole person. We know that having diabetes is a risk factor for ASCVD, microvascular and microvascular complications, heart failure and stroke, to name a few. Chris Memering, MSN, RN, CDCES, FADCES shares her thoughts on the importance of developing your cardiovascular expertise when working with people with diabetes.

  • What You Need To Know about Tirzepatide (Mounjaro ™)

    By ADCES Perspectives on Diabetes Care | Jul 06, 2022

    In May 2022, the FDA approved another GLP-1 agonist, tirzepatide (Mounjaro ™) for the treatment of type 2 diabetes mellitus. Mark A. Smith, Jr., PharmD, CDCES, AFAA-CGFI summarize what diabetes care and education specialists need to know about this medication and its role in diabetes management and weight loss.

 
In This Section

News & Publications